HomeComparePLGNF vs PFE

PLGNF vs PFE: Dividend Comparison 2026

PLGNF yields 50000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLGNF wins by $4.789070889867552e+23M in total portfolio value
10 years
PLGNF
PLGNF
● Live price
50000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.789070889867552e+23M
Annual income
$477,030,307,353,597,400,000,000,000,000.00
Full PLGNF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PLGNF vs PFE

📍 PLGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPLGNFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PLGNF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PLGNF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PLGNF
Annual income on $10K today (after 15% tax)
$4,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$405,475,761,250,557,800,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PLGNF beats the other by $405,475,761,250,557,800,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PLGNF + PFE for your $10,000?

PLGNF: 50%PFE: 50%
100% PFE50/50100% PLGNF
Portfolio after 10yr
$2.394535444933776e+23M
Annual income
$238,515,153,676,798,700,000,000,000,000.00/yr
Blended yield
99.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PLGNF
No analyst data
Altman Z
-212.9
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PLGNF buys
0
PFE buys
0
No recent congressional trades found for PLGNF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPLGNFPFE
Forward yield50000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.789070889867552e+23M$49.6K
Annual income after 10y$477,030,307,353,597,400,000,000,000,000.00$26,258.71
Total dividends collected$4.7878388715795706e+23M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PLGNF vs PFE ($10,000, DRIP)

YearPLGNF PortfolioPLGNF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$5,010,700$5,000,000.00$9,153$693.39+$5.00MPLGNF
2$2,346,810,047$2,341,448,598.13$8,593$849.25+$2346.80MPLGNF
3$1,027,408,478,283$1,024,897,391,532.38$8,336$1,066.78+$1027408.47MPLGNF
4$420,435,006,832,721$419,335,679,760,958.80$8,437$1,384.80+$420435006.82MPLGNF
5$160,823,792,302,236,830$160,373,926,844,925,820.00$9,013$1,875.40+$160823792302.23MPLGNF
6$57,504,652,079,586,796,000$57,332,570,621,823,390,000.00$10,306$2,680.72+$57504652079586.79MPLGNF
7$19,220,418,850,978,506,000,000$19,158,888,873,253,350,000,000.00$12,820$4,101.38+$19220418850978508.00MPLGNF
8$6,005,321,287,350,842,000,000,000$5,984,755,439,180,295,000,000,000.00$17,673$6,826.70+$6005321287350842368.00MPLGNF
9$1,754,001,526,315,678,800,000,000,000$1,747,575,832,538,213,200,000,000,000.00$27,543$12,591.86+$1.7540015263156787e+21MPLGNF
10$478,907,088,986,755,200,000,000,000,000$477,030,307,353,597,400,000,000,000,000.00$49,560$26,258.71+$4.789070889867552e+23MPLGNF

PLGNF vs PFE: Complete Analysis 2026

PLGNFStock

Playgon Games Inc. engages in the development and licensing of digital content for the iGaming market. The company offers daily fantasy sports (DFS) software and network, which is licensed to customers to offer a customized and branded DFS product to their end users. It also provides a multi-tenant gateway that allows online operators to offer their customers iGaming software solutions. In addition, the company focuses on developing digital content for the iGaming market. It offers its solutions for online casinos, sportsbook operators, land-based operators, media groups, and big database companies. The company was formerly known as Global Daily Fantasy Sports Inc. and changed its name to Playgon Games Inc. in July 2020. Playgon Games Inc. was incorporated in 1985 and is based in Vancouver, Canada.

Full PLGNF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PLGNF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PLGNF vs SCHDPLGNF vs JEPIPLGNF vs OPLGNF vs KOPLGNF vs MAINPLGNF vs JNJPLGNF vs MRKPLGNF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.